Poland

Poland

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.44 (0.39 - 0.49) 2019 Modelled IHME
0.44 (0.39 - 0.50) 2018 Modelled IHME
0.45 (0.40 - 0.50) 2017 Modelled IHME
0.46 (0.41 - 0.51) 2016 Modelled IHME
0.48 (0.42 - 0.53) 2015 Modelled IHME
0.49 (0.44 - 0.55) 2014 Modelled IHME
0.51 (0.45 - 0.57) 2013 Modelled IHME
0.53 (0.47 - 0.59) 2012 Modelled IHME
0.55 (0.48 - 0.61) 2011 Modelled IHME
0.57 (0.50 - 0.63) 2010 Modelled IHME
0.59 (0.52 - 0.66) 2009 Modelled IHME
0.61 (0.53 - 0.68) 2008 Modelled IHME
0.63 (0.55 - 0.70) 2007 Modelled IHME
0.65 (0.57 - 0.72) 2006 Modelled IHME
0.67 (0.59 - 0.74) 2005 Modelled IHME
0.69 (0.61 - 0.77) 2004 Modelled IHME
0.71 (0.64 - 0.79) 2003 Modelled IHME
0.74 (0.66 - 0.81) 2002 Modelled IHME
0.76 (0.68 - 0.84) 2001 Modelled IHME
0.78 (0.70 - 0.86) 2000 Modelled IHME
0.8 (0.72 - 0.88) 1999 Modelled IHME
0.82 (0.74 - 0.90) 1998 Modelled IHME
0.84 (0.75 - 0.92) 1997 Modelled IHME
0.85 (0.77 - 0.94) 1996 Modelled IHME
0.87 (0.78 - 0.96) 1995 Modelled IHME
0.88 (0.80 - 0.97) 1994 Modelled IHME
0.89 (0.81 - 0.98) 1993 Modelled IHME
0.9 (0.82 - 1) 1992 Modelled IHME
0.91 (0.82 - 1.01) 1991 Modelled IHME
0.92 (0.83 - 1.02) 1990 Modelled IHME
0.32 (0.23 - 0.42) 2015 Modelled WHO
0.9 (0.70 - 1.10) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.02 (0.02 - 0.03) 2019 Modelled IHME
0.02 (0.02 - 0.03) 2018 Modelled IHME
0.02 (0.02 - 0.03) 2017 Modelled IHME
0.02 (0.02 - 0.03) 2016 Modelled IHME
0.02 (0.02 - 0.03) 2015 Modelled IHME
0.02 (0.02 - 0.03) 2014 Modelled IHME
0.02 (0.02 - 0.03) 2013 Modelled IHME
0.02 (0.02 - 0.03) 2012 Modelled IHME
0.02 (0.02 - 0.03) 2011 Modelled IHME
0.02 (0.02 - 0.03) 2010 Modelled IHME
0.02 (0.02 - 0.03) 2009 Modelled IHME
0.02 (0.02 - 0.03) 2008 Modelled IHME
0.02 (0.02 - 0.03) 2007 Modelled IHME
0.02 (0.02 - 0.03) 2006 Modelled IHME
0.02 (0.02 - 0.03) 2005 Modelled IHME
0.02 (0.02 - 0.03) 2004 Modelled IHME
0.02 (0.02 - 0.03) 2003 Modelled IHME
0.02 (0.02 - 0.03) 2002 Modelled IHME
0.02 (0.02 - 0.03) 2001 Modelled IHME
0.02 (0.02 - 0.03) 2000 Modelled IHME
0.05 (0.03 - 0.06) 1999 Modelled IHME
0.1 (0.08 - 0.12) 1998 Modelled IHME
0.17 (0.13 - 0.21) 1997 Modelled IHME
0.24 (0.18 - 0.29) 1996 Modelled IHME
0.28 (0.22 - 0.35) 1995 Modelled IHME
0.31 (0.24 - 0.39) 1994 Modelled IHME
0.34 (0.26 - 0.42) 1993 Modelled IHME
0.36 (0.28 - 0.45) 1992 Modelled IHME
0.38 (0.29 - 0.47) 1991 Modelled IHME
0.39 (0.30 - 0.48) 1990 Modelled IHME
0.04 (0.02 - 0.06) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
351,945 (317,248 - 390,422) 1990 Modelled IHME
349,652 (315,127 - 387,316) 1991 Modelled IHME
346,523 (312,817 - 382,806) 1992 Modelled IHME
342,736 (309,649 - 377,299) 1993 Modelled IHME
338,344 (305,900 - 373,122) 1994 Modelled IHME
333,410 (301,185 - 368,104) 1995 Modelled IHME
327,740 (295,851 - 360,942) 1996 Modelled IHME
321,191 (289,752 - 353,512) 1997 Modelled IHME
313,979 (282,957 - 346,103) 1998 Modelled IHME
306,309 (275,318 - 338,479) 1999 Modelled IHME
298,441 (267,884 - 330,435) 2000 Modelled IHME
290,137 (260,145 - 321,274) 2001 Modelled IHME
281,207 (252,110 - 311,550) 2002 Modelled IHME
272,051 (243,299 - 301,483) 2003 Modelled IHME
263,063 (234,117 - 292,315) 2004 Modelled IHME
254,641 (226,122 - 283,594) 2005 Modelled IHME
246,814 (218,810 - 275,027) 2006 Modelled IHME
239,307 (211,529 - 266,437) 2007 Modelled IHME
232,050 (204,665 - 258,352) 2008 Modelled IHME
224,951 (198,115 - 251,066) 2009 Modelled IHME
217,927 (191,426 - 243,465) 2010 Modelled IHME
210,766 (185,351 - 235,841) 2011 Modelled IHME
203,450 (179,524 - 226,931) 2012 Modelled IHME
196,242 (173,323 - 217,916) 2013 Modelled IHME
189,445 (167,810 - 210,597) 2014 Modelled IHME
183,302 (162,111 - 203,305) 2015 Modelled IHME
177,359 (156,835 - 198,067) 2016 Modelled IHME
173,162 (152,675 - 193,508) 2017 Modelled IHME
171,109 (151,450 - 191,035) 2018 Modelled IHME
170,081 (150,631 - 189,962) 2019 Modelled IHME
359,000 (269,000 - 438,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.57 (3.59 - 5.73) 2019 Modelled IHME
4.57 (3.67 - 5.62) 2018 Modelled IHME
4.56 (3.80 - 5.38) 2017 Modelled IHME
4.57 (3.94 - 5.24) 2016 Modelled IHME
4.57 (3.94 - 5.26) 2015 Modelled IHME
4.46 (3.84 - 5.16) 2014 Modelled IHME
4.61 (3.97 - 5.30) 2013 Modelled IHME
4.71 (4.04 - 5.41) 2012 Modelled IHME
4.69 (4.02 - 5.40) 2011 Modelled IHME
4.73 (4.07 - 5.46) 2010 Modelled IHME
5.07 (4.40 - 5.83) 2009 Modelled IHME
5.64 (4.93 - 6.45) 2008 Modelled IHME
6.21 (5.48 - 7.04) 2007 Modelled IHME
6.54 (5.81 - 7.34) 2006 Modelled IHME
6.62 (5.92 - 7.39) 2005 Modelled IHME
6.56 (5.89 - 7.32) 2004 Modelled IHME
6.39 (5.74 - 7.10) 2003 Modelled IHME
6.43 (5.77 - 7.12) 2002 Modelled IHME
6.51 (5.88 - 7.20) 2001 Modelled IHME
6.57 (5.94 - 7.28) 2000 Modelled IHME
6.84 (6.17 - 7.53) 1999 Modelled IHME
6.68 (6.05 - 7.38) 1998 Modelled IHME
6.72 (6.11 - 7.42) 1997 Modelled IHME
6.69 (6.09 - 7.35) 1996 Modelled IHME
6.86 (6.24 - 7.55) 1995 Modelled IHME
6.69 (6.12 - 7.34) 1994 Modelled IHME
6.66 (6.07 - 7.32) 1993 Modelled IHME
6.88 (6.27 - 7.55) 1992 Modelled IHME
7 (6.36 - 7.68) 1991 Modelled IHME
6.66 (6.05 - 7.32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,755 (1,380 - 2,203) 2019 Modelled IHME
1,756 (1,412 - 2,160) 2018 Modelled IHME
1,755 (1,464 - 2,069) 2017 Modelled IHME
1,757 (1,514 - 2,016) 2016 Modelled IHME
1,757 (1,516 - 2,025) 2015 Modelled IHME
1,715 (1,477 - 1,985) 2014 Modelled IHME
1,775 (1,526 - 2,040) 2013 Modelled IHME
1,812 (1,555 - 2,082) 2012 Modelled IHME
1,800 (1,543 - 2,073) 2011 Modelled IHME
1,814 (1,561 - 2,094) 2010 Modelled IHME
1,944 (1,686 - 2,234) 2009 Modelled IHME
2,159 (1,888 - 2,467) 2008 Modelled IHME
2,372 (2,094 - 2,689) 2007 Modelled IHME
2,496 (2,221 - 2,805) 2006 Modelled IHME
2,527 (2,262 - 2,822) 2005 Modelled IHME
2,503 (2,248 - 2,795) 2004 Modelled IHME
2,442 (2,194 - 2,711) 2003 Modelled IHME
2,457 (2,207 - 2,721) 2002 Modelled IHME
2,492 (2,251 - 2,756) 2001 Modelled IHME
2,517 (2,275 - 2,788) 2000 Modelled IHME
2,620 (2,363 - 2,887) 1999 Modelled IHME
2,564 (2,321 - 2,831) 1998 Modelled IHME
2,579 (2,347 - 2,847) 1997 Modelled IHME
2,567 (2,339 - 2,821) 1996 Modelled IHME
2,633 (2,398 - 2,898) 1995 Modelled IHME
2,571 (2,350 - 2,817) 1994 Modelled IHME
2,555 (2,328 - 2,808) 1993 Modelled IHME
2,635 (2,402 - 2,892) 1992 Modelled IHME
2,676 (2,434 - 2,938) 1991 Modelled IHME
2,541 (2,309 - 2,792) 1990 Modelled IHME
2,081 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
18 (15 - 21) 2019 Modelled IHME
18 (15 - 21) 2018 Modelled IHME
18 (15 - 21) 2017 Modelled IHME
18 (15 - 21) 2016 Modelled IHME
18 (15 - 21) 2015 Modelled IHME
18 (15 - 21) 2014 Modelled IHME
18 (16 - 21) 2013 Modelled IHME
18 (16 - 22) 2012 Modelled IHME
18 (16 - 22) 2011 Modelled IHME
19 (16 - 22) 2010 Modelled IHME
19 (16 - 22) 2009 Modelled IHME
19 (16 - 23) 2008 Modelled IHME
20 (17 - 24) 2007 Modelled IHME
21 (18 - 24) 2006 Modelled IHME
21 (18 - 25) 2005 Modelled IHME
21 (18 - 25) 2004 Modelled IHME
22 (18 - 25) 2003 Modelled IHME
22 (19 - 26) 2002 Modelled IHME
22 (19 - 26) 2001 Modelled IHME
22 (19 - 26) 2000 Modelled IHME
22 (19 - 26) 1999 Modelled IHME
22 (19 - 26) 1998 Modelled IHME
22 (19 - 26) 1997 Modelled IHME
22 (19 - 26) 1996 Modelled IHME
22 (19 - 26) 1995 Modelled IHME
22 (19 - 26) 1994 Modelled IHME
22 (19 - 26) 1993 Modelled IHME
22 (19 - 26) 1992 Modelled IHME
22 (19 - 26) 1991 Modelled IHME
22 (19 - 26) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
93 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
93 2016 Survey/reported WHO/UNICEF
93 2015 Survey/reported WHO/UNICEF
93 2014 Survey/reported WHO/UNICEF
93 2013 Survey/reported WHO/UNICEF
93 2012 Survey/reported WHO/UNICEF
93 2011 Survey/reported WHO/UNICEF
93 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
93 2007 Survey/reported WHO/UNICEF
93 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
93 2004 Survey/reported WHO/UNICEF
92 2003 Survey/reported WHO/UNICEF
94 2002 Survey/reported WHO/UNICEF
94 2001 Survey/reported WHO/UNICEF
95 2000 Survey/reported WHO/UNICEF
93 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
95 2016 Survey/reported WHO/UNICEF
96 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
96 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
98 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
97 2003 Survey/reported WHO/UNICEF
98 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
99 1999 Survey/reported WHO/UNICEF
99 1998 Survey/reported WHO/UNICEF
97 1997 Survey/reported WHO/UNICEF
56 1996 Survey/reported WHO/UNICEF
23 1995 Survey/reported WHO/UNICEF
4 1994 Survey/reported WHO/UNICEF
1 1993 Survey/reported WHO/UNICEF
1 1992 Survey/reported WHO/UNICEF
1 1991 Survey/reported WHO/UNICEF
91 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
18 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2001
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.13 (0.91 - 1.40) 2019 Modelled IHME
1.12 (0.90 - 1.38) 2018 Modelled IHME
1.11 (0.90 - 1.37) 2017 Modelled IHME
1.13 (0.91 - 1.39) 2016 Modelled IHME
1.14 (0.92 - 1.40) 2015 Modelled IHME
1.14 (0.92 - 1.41) 2014 Modelled IHME
1.15 (0.92 - 1.41) 2013 Modelled IHME
1.15 (0.92 - 1.42) 2012 Modelled IHME
1.15 (0.92 - 1.43) 2011 Modelled IHME
1.15 (0.92 - 1.42) 2010 Modelled IHME
1.14 (0.91 - 1.42) 2009 Modelled IHME
1.14 (0.91 - 1.41) 2008 Modelled IHME
1.13 (0.91 - 1.41) 2007 Modelled IHME
1.12 (0.90 - 1.39) 2006 Modelled IHME
1.11 (0.89 - 1.38) 2005 Modelled IHME
1.1 (0.88 - 1.36) 2004 Modelled IHME
1.08 (0.87 - 1.34) 2003 Modelled IHME
1.07 (0.85 - 1.32) 2002 Modelled IHME
1.05 (0.84 - 1.30) 2001 Modelled IHME
1.04 (0.83 - 1.29) 2000 Modelled IHME
1.03 (0.82 - 1.27) 1999 Modelled IHME
1.02 (0.82 - 1.26) 1998 Modelled IHME
1.02 (0.81 - 1.25) 1997 Modelled IHME
1.01 (0.81 - 1.25) 1996 Modelled IHME
1.01 (0.81 - 1.25) 1995 Modelled IHME
1.01 (0.81 - 1.25) 1994 Modelled IHME
1.03 (0.82 - 1.27) 1993 Modelled IHME
1.04 (0.83 - 1.30) 1992 Modelled IHME
1.07 (0.85 - 1.33) 1991 Modelled IHME
1.09 (0.87 - 1.36) 1990 Modelled IHME
0.5 (0.40 - 0.60) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.1 (1 - 1.20) 2016 Survey/reported Parda N, 2016
1.5 (1.30 - 1.70) 2014 Survey/reported Walewska-Zielecka, 2016
0.8 (0.30 - 1.60) 2006 Survey/reported Clifford, 2017
0.9 (0.60 - 1.10) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
58.7 (55.10 - 62.20) 2005 Survey/reported Rosinska M et al, 2015
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
416,368 (331,722 - 519,958) 1990 Modelled IHME
407,564 (325,627 - 507,495) 1991 Modelled IHME
399,772 (319,597 - 497,172) 1992 Modelled IHME
393,615 (314,822 - 487,521) 1993 Modelled IHME
389,562 (311,595 - 480,922) 1994 Modelled IHME
388,090 (310,606 - 478,287) 1995 Modelled IHME
388,648 (310,820 - 478,927) 1996 Modelled IHME
390,134 (312,082 - 481,012) 1997 Modelled IHME
392,283 (313,628 - 483,555) 1998 Modelled IHME
394,811 (315,219 - 487,585) 1999 Modelled IHME
397,510 (317,031 - 492,154) 2000 Modelled IHME
401,618 (320,046 - 497,120) 2001 Modelled IHME
407,646 (324,779 - 504,722) 2002 Modelled IHME
414,405 (331,148 - 512,758) 2003 Modelled IHME
420,711 (336,254 - 520,339) 2004 Modelled IHME
425,394 (339,991 - 526,270) 2005 Modelled IHME
428,991 (343,320 - 532,245) 2006 Modelled IHME
432,593 (346,178 - 537,193) 2007 Modelled IHME
435,855 (348,758 - 541,425) 2008 Modelled IHME
438,378 (350,189 - 544,654) 2009 Modelled IHME
439,765 (352,188 - 546,225) 2010 Modelled IHME
440,340 (351,962 - 548,204) 2011 Modelled IHME
440,622 (353,172 - 546,552) 2012 Modelled IHME
440,628 (353,407 - 544,128) 2013 Modelled IHME
440,464 (354,573 - 540,997) 2014 Modelled IHME
440,112 (353,766 - 538,678) 2015 Modelled IHME
434,250 (348,832 - 534,533) 2016 Modelled IHME
428,595 (345,334 - 527,957) 2017 Modelled IHME
429,140 (345,928 - 531,625) 2018 Modelled IHME
432,584 (348,972 - 537,079) 2019 Modelled IHME
184,000 (136,000 - 224,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
5.1 (4.09 - 6.39) 2019 Modelled IHME
5.1 (4.16 - 6.12) 2018 Modelled IHME
5.08 (4.33 - 5.98) 2017 Modelled IHME
5.1 (4.47 - 5.84) 2016 Modelled IHME
5.1 (4.46 - 5.85) 2015 Modelled IHME
4.98 (4.35 - 5.69) 2014 Modelled IHME
5.14 (4.51 - 5.88) 2013 Modelled IHME
5.25 (4.60 - 6) 2012 Modelled IHME
5.21 (4.57 - 5.97) 2011 Modelled IHME
5.24 (4.61 - 5.99) 2010 Modelled IHME
5.32 (4.66 - 6.09) 2009 Modelled IHME
5.24 (4.60 - 5.98) 2008 Modelled IHME
5.05 (4.42 - 5.77) 2007 Modelled IHME
4.74 (4.17 - 5.43) 2006 Modelled IHME
4.48 (3.96 - 5.12) 2005 Modelled IHME
4.27 (3.77 - 4.87) 2004 Modelled IHME
4.04 (3.58 - 4.59) 2003 Modelled IHME
3.95 (3.51 - 4.48) 2002 Modelled IHME
3.94 (3.49 - 4.47) 2001 Modelled IHME
3.96 (3.52 - 4.49) 2000 Modelled IHME
4.15 (3.70 - 4.70) 1999 Modelled IHME
4.23 (3.78 - 4.74) 1998 Modelled IHME
4.43 (3.97 - 4.96) 1997 Modelled IHME
4.63 (4.15 - 5.15) 1996 Modelled IHME
4.87 (4.37 - 5.40) 1995 Modelled IHME
4.89 (4.39 - 5.41) 1994 Modelled IHME
4.98 (4.47 - 5.49) 1993 Modelled IHME
5.2 (4.69 - 5.74) 1992 Modelled IHME
5.36 (4.83 - 5.91) 1991 Modelled IHME
5.23 (4.71 - 5.76) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,960 (1,571 - 2,454) 2019 Modelled IHME
1,960 (1,599 - 2,355) 2018 Modelled IHME
1,957 (1,668 - 2,303) 2017 Modelled IHME
1,961 (1,721 - 2,247) 2016 Modelled IHME
1,961 (1,716 - 2,253) 2015 Modelled IHME
1,915 (1,675 - 2,191) 2014 Modelled IHME
1,979 (1,733 - 2,260) 2013 Modelled IHME
2,018 (1,769 - 2,309) 2012 Modelled IHME
2,002 (1,754 - 2,293) 2011 Modelled IHME
2,012 (1,770 - 2,297) 2010 Modelled IHME
2,039 (1,787 - 2,335) 2009 Modelled IHME
2,005 (1,762 - 2,290) 2008 Modelled IHME
1,929 (1,691 - 2,206) 2007 Modelled IHME
1,812 (1,594 - 2,075) 2006 Modelled IHME
1,711 (1,514 - 1,955) 2005 Modelled IHME
1,630 (1,439 - 1,858) 2004 Modelled IHME
1,542 (1,366 - 1,752) 2003 Modelled IHME
1,511 (1,341 - 1,713) 2002 Modelled IHME
1,507 (1,337 - 1,710) 2001 Modelled IHME
1,517 (1,346 - 1,721) 2000 Modelled IHME
1,592 (1,417 - 1,803) 1999 Modelled IHME
1,621 (1,451 - 1,819) 1998 Modelled IHME
1,701 (1,525 - 1,906) 1997 Modelled IHME
1,777 (1,594 - 1,978) 1996 Modelled IHME
1,870 (1,677 - 2,075) 1995 Modelled IHME
1,878 (1,685 - 2,076) 1994 Modelled IHME
1,911 (1,716 - 2,106) 1993 Modelled IHME
1,993 (1,796 - 2,200) 1992 Modelled IHME
2,050 (1,848 - 2,261) 1991 Modelled IHME
1,995 (1,796 - 2,198) 1990 Modelled IHME
1,878 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
26 (22 - 30) 2019 Modelled IHME
26 (23 - 30) 2018 Modelled IHME
26 (23 - 30) 2017 Modelled IHME
26 (23 - 29) 2016 Modelled IHME
26 (23 - 29) 2015 Modelled IHME
26 (23 - 29) 2014 Modelled IHME
26 (23 - 30) 2013 Modelled IHME
26 (23 - 30) 2012 Modelled IHME
26 (23 - 30) 2011 Modelled IHME
26 (23 - 30) 2010 Modelled IHME
26 (23 - 30) 2009 Modelled IHME
26 (23 - 30) 2008 Modelled IHME
27 (23 - 30) 2007 Modelled IHME
27 (23 - 30) 2006 Modelled IHME
26 (23 - 30) 2005 Modelled IHME
26 (23 - 30) 2004 Modelled IHME
26 (23 - 30) 2003 Modelled IHME
27 (23 - 30) 2002 Modelled IHME
27 (23 - 30) 2001 Modelled IHME
27 (23 - 30) 2000 Modelled IHME
27 (24 - 31) 1999 Modelled IHME
28 (24 - 31) 1998 Modelled IHME
28 (25 - 32) 1997 Modelled IHME
29 (25 - 32) 1996 Modelled IHME
29 (26 - 33) 1995 Modelled IHME
29 (26 - 33) 1994 Modelled IHME
29 (26 - 33) 1993 Modelled IHME
29 (26 - 33) 1992 Modelled IHME
29 (26 - 33) 1991 Modelled IHME
30 (26 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
18 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2001
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
1,755
2019
(1,380 - 2,203)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,960
2019
(1,571 - 2,454)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
93 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines